Andrew G Myers

This inventor holds 41 USPTO granted patents and 12 published patent applications, plus 6 CIPO patents and 14 EPO patents, primarily in Antibiotic Synthesis. Top assignees: Harvard College, President and Fellows of Havard College, Zikani Therapeutics, Inc.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew G Myers. Retrieved from https://idiyas.com/inventor/andrew-g-myers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 (Patent Applications = 12)

% Patents Active = 78.0

CIPO Patents = 6 (Patent Applications = 6)

EPO Patents = 14 (Patent Applications = 17)

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 165(Granted Patents)

Location History:

Boston, MA (US) (2004 - 2023)
Cambridge, MA (US) (2021 - 2023)

Company Filing History:

President and Fellows of Havard College

patents

1 out of 1

Zikani Therapeutics, Inc.

patent

4. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Macrolides

Lincosamides

Tetracyclines

Cortistatin Analogues

Trioxacarcins

Enone Intermediate

Saframycins

Antibody Conjugates

Biological Targets

Synthesis

Analogs

Desosamines

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721904 - Stabilized trioxacarcin antibody drug conjugates and uses thereof (2026-09-01),

2. 12552825 - C10-alkylene substituted 13-membered macrolides and uses thereof (2026-02-17),

3. 11767341 - Lincosamide antibiotics and uses thereof (2023-09-26),

4. 11673910 - Macrolides with modified desosamine sugars and uses thereof (2023-06-13),

5. 11634449 - Macrolides and methods of their preparation and use (2023-04-25),

6. 11566039 - Lincosamide antibiotics and uses thereof (2023-01-31),

7. 11535643 - Macrolides with modified desosamine sugars and uses thereof (2022-12-27),

8. 11466046 - 14-membered ketolides and methods of their preparation and use (2022-10-11),

9. 11192866 - Synthesis of tetracyclines and analogues thereof (2021-12-07),

10. 11124534 - Lincosamide antibiotics and uses thereof (2021-09-21),

11. 11008358 - Synthesis of desosamines (2021-05-18),

12. 10913764 - Macrolides and methods of their preparation and use (2021-02-09),

13. 10669244 - Synthesis of tetracyclines and analogues thereof (2020-06-02),

14. 10640528 - Macrolides with modified desosamine sugars and uses thereof (2020-05-05),

15. 10639381 - Trioxacarcins, trioxacarcin#antibody conjugates, and uses thereof (2020-05-05),

Title: Unveiling the Inventive Genius of Andrew G Myers in Boston, MA

Introduction:

Andrew G Myers is a distinguished inventor based in Boston, MA, with a remarkable portfolio of 39 patents to his name. His groundbreaking work in the field of pharmaceuticals has revolutionized the treatment of infectious diseases, showcasing his ingenuity and commitment to innovation.

Latest Patents:

Andrew G Myers' latest patents include the development of lincosamide antibiotics and their applications in combating infectious diseases. These modified lincosamide compounds offer a novel approach to treating various infections by targeting specific regions within the bacterial structure. Additionally, his work on macrolides with modified desosamine sugars has paved the way for more effective treatments against Gram-negative bacteria.

Career Highlights:

Throughout his career, Andrew G Myers has been associated with prestigious institutions such as the President and Fellows of Harvard College, where he has conducted groundbreaking research in the field of pharmaceuticals. His expertise in organic chemistry and drug development has earned him recognition as a trailblazer in the field of medicinal chemistry.

Collaborations:

Andrew G Myers has collaborated with esteemed professionals in the industry, including colleagues such as Jason D Brubaker and Ziyang Zhang. Together, they have worked on cutting-edge projects that have led to significant advancements in the field of antibiotic development and infectious disease treatment.

Conclusion:

In conclusion, Andrew G Myers stands as a pioneer in the field of pharmaceutical innovation, with a rich legacy of patents that have reshaped the landscape of modern medicine. His dedication to pushing the boundaries of scientific discovery continues to inspire the next generation of inventors and researchers in the quest for improved healthcare solutions.

Profile summary based on public USPTO records.